Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 4 Papillomavirus Infections 3 Inflammation 2 Frailty 2 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Squamous Intraepithelial Lesions 1 Radiodermatitis 1 Prostatic Neoplasms 1 Papilloma 1 Liver Neoplasms 1 Liver Cirrhosis 1 Fibrosis 1 Esophageal Neoplasms 1 Deglutition Disorders 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Atypical Squamous Cells of the Cervix 1

Interventions

Magnetic Resonance Spectroscopy 5 Pentoxifylline 4 Liver Transplantation 4 Blood Specimen Collection 4 Specimen Handling 3 High-Energy Shock Waves 3 Tocopherols 2 Sorafenib 2 Simvastatin 2 Low-Level Light Therapy 2 Gemcitabine 2 tremelimumab 1 sonidegib 1 sofosbuvir-velpatasvir drug combination 1 ruxolitinib 1 navitoclax 1 maltodextrin 1 esmolol 1 epigallocatechin gallate 1 durvalumab 1 contrast agent BR1 1 bavituximab 1 atezolizumab 1 apixaban 1 alpha-Tocopherol 1 Viusid 1 Vitamin E 1 Vitamin D 1 Tenofovir 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Fibrosis × epigallocatechin gallate × Clear all

NCT07149506 2025-09-08

OCTOPUS-RD

Universidad de Guanajuato

Phase 3 Enrolling by invitation

Fibrosis, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡